GMR Solutions, Inc. Class A AI Stock Analysis
Want to see GMRS full AI Analyst Report?
GMR Solutions, Inc. Class A (GMRS) AI Stock Analysis
GMR Solutions, Inc. Class A
(NYSE:GMRS)
GMRS scores in the upper-middle range primarily because improving profitability/cash generation and a very low P/E are tempered by significant balance-sheet leverage risk. The earnings call was net constructive (growth, liquidity and deleveraging) but included notable headwinds and a revenue guidance reduction. Technically, signals are mildly positive but not strongly bullish.
GMR Solutions, Inc. Class A (GMRS) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $610.45M
- Dividend Yield
- ―
- Average Volume (3M)
- 983.53K
- Price to Earnings (P/E)
- 2.8
- Beta (1Y)
- 0.43
- Revenue Growth
- ―
- EPS Growth
- ―
- Country
- US
- Employees
- 33,858
- Sector
- General
- Sector Strength
- 55
- Industry
- Medical - Care Facilities
GMR Solutions, Inc. Class A Business Overview & Revenue Model
Company Description
GMR Solutions Inc., headquartered in Lewisville, Texas, is a leading U.S.-based company specializing in comprehensive out-of-hospital healthcare and mobile clinical services. The organization delivers both emergency and non-emergency medical care. Be...
GMR Solutions, Inc. Class A Earnings Call Summary
The call was broadly positive, with continued revenue, adjusted EBITDA and free cash flow growth, healthy emergent demand, strong Nurse Navigation and new-market expansion, improved liquidity and meaningful deleveraging. These positives were tempered by a lower revenue outlook, elevated fuel and inflationary costs, weather-related air cancellations, payer-mix pressure, No Surprises Act collection delays and a fatal rotor accident. Highlights significantly outweighed the stated challenges.
Q3-2026 Updates
Positive Updates
Negative Updates
Company Guidance
GMR now expects 2026 revenue to be in the range of $5.9 billion to $6.05 billion, lowering the top end and bringing the midpoint down to $5.975 billion, while maintaining full year adjusted EBITDA in the range of $1.135 billion to $1.195 billion; total cash used for CapEx and aircraft financing is expected to be between 5.2% and 5.4% of total revenue. NRTs are expected in the fourth quarter to be in that low to mid-single digits, with the ACA exchanges representing a $16 million run rate, while change of estimates related to IDR claims are expected to drive closer to 0. GMR’s long-term goal remains mid-single-digit plus revenue growth and high single-digit EBITDA growth, with line of sight to approximately 3.0x before the end of the year in 2027.
GMR Solutions, Inc. Class A Financial Statement Overview
Summary
Operating results improved meaningfully (return to profitability and stronger 2025 earnings, with solid gross and operating margins), and 2025 cash flow rebounded with positive free cash flow. However, the balance sheet is a major constraint: very high leverage and thin equity materially increase financial risk and reduce flexibility.
Income Statement
58NeutralBalance Sheet
22NegativeCash Flow
46Neutral| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 |
|---|---|---|---|---|
Income Statement | ||||
| Total Revenue | 4.54B | 5.74B | 5.98B | 5.39B |
| Gross Profit | 2.52B | 2.23B | 2.44B | 2.08B |
| EBITDA | 788.70M | 1.07B | 911.57M | 675.02M |
| Net Income | 213.61M | 206.23M | 20.41M | -202.66M |
Balance Sheet | ||||
| Total Assets | 7.52B | 7.48B | 7.12B | 7.05B |
| Cash, Cash Equivalents and Short-Term Investments | 297.99M | 687.96M | 434.81M | 127.26M |
| Total Debt | 4.60B | 5.37B | 4.86B | 5.65B |
| Total Liabilities | 6.61B | 7.28B | 6.93B | 7.05B |
| Stockholders Equity | 908.27M | 204.16M | 188.00M | -2.37M |
Cash Flow | ||||
| Free Cash Flow | 64.61M | 382.60M | -22.41M | 86.74M |
| Operating Cash Flow | 128.74M | 641.15M | 246.21M | 257.75M |
| Investing Cash Flow | -51.46M | -249.97M | 47.97M | -142.97M |
| Financing Cash Flow | -264.82M | -135.84M | -59.24M | -142.18M |
GMR Solutions, Inc. Class A Peers Comparison
Overall Rating
ADUS83Outperform
AVAH68Neutral
USPH66Neutral
AMN59Neutral
GMRS58Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 83Outperform | $2.34B | 20.65 | 9.81% | ― | 11.53% | 27.72% | |
| 68Neutral | $2.86B | 8.40 | 115.53% | ― | 16.84% | 280.13% | |
| 66Neutral | $1.49B | -73.10 | -0.49% | 1.86% | 10.40% | -156.70% | |
| 59Neutral | $1.46B | 13.47 | 15.19% | ― | 29.45% | ― | |
| 58Neutral | $635.30M | 2.84 | 46.23% | ― | ― | ― | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| GMRS | GMR Solutions, Inc. Class A | 11.30 | -2.68 | -19.17% | |
| ADUS | Addus HomeCare Corporation | 123.72 | 14.65 | 13.43% | |
| AMN | AMN Healthcare | 37.42 | 21.53 | 135.49% | |
| USPH | U.s. Physical Therapy | 98.60 | 28.73 | 41.13% | |
| AVAH | Aveanna Healthcare Holdings Inc | 12.24 | 3.79 | 44.85% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 12, 2026
